Table 5 Correlation between CD47highCD68high and clinicopathological parameters in hormone receptor-negative breast cancer
From: Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients
Clinicopathological factors | n | CD47highCD68high (%) | χ2 | P |
|---|---|---|---|---|
Age (years) | ||||
< 50 | 54 | 64.81 | 0.034 | 0.853 |
> 50 | 39 | 66.67 | ||
Menopause | ||||
Before | 44 | 61.36 | 0.661 | 0.416 |
After | 49 | 69.39 | ||
TNM stage | ||||
I | 3 | 33.33 | 14.997 | 0.001 |
II | 57 | 52.63 | ||
III | 33 | 90.91 | ||
Histological grade | ||||
G1 | 7 | 85.71 | 11.714 | 0.003 |
G2 | 47 | 48.94 | ||
G3 | 39 | 82.05 | ||
Lymph node metastasis | ||||
Yes | 54 | 75.93 | 6.094 | 0.014 |
No | 39 | 51.28 | ||
Recurrence | ||||
Yes | 50 | 76.00 | 5.191 | 0.023 |
No | 43 | 53.49 | ||